Cadila Healthcare Limited has informed the Exchange regarding a press release dated October 22, 2021, titled " Zydus announces first patient randomised in EVIDENCES-XTM Phase II(b) clinical trial of Saroglitazar Mg in NASH ".
Press Release Oct 22 2021
Filed with NSE · · 4 pages · English
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Oct 08 2021
- Press Release Sep 24 2021
- Press Release Sep 18 2021
- Press Release Sep 09 2021
- Press Release Sep 06 2021
Later from Zydus Lifesciences
- Press Release Nov 08 2021
- Press Release Nov 10 2021
- Press Release Nov 12 2021
- Press Release Nov 18 2021
- Press Release Nov 20 2021
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences